IRIS
BIANCHI, GIOVANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 22.278
AS - Asia 2.092
NA - Nord America 1.109
SA - Sud America 164
AF - Africa 30
OC - Oceania 2
Totale 25.675
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 21.897
US - Stati Uniti d'America 1.020
SG - Singapore 899
CN - Cina 541
VN - Vietnam 348
FR - Francia 182
BR - Brasile 97
BD - Bangladesh 87
HK - Hong Kong 78
FI - Finlandia 53
DE - Germania 39
JP - Giappone 36
AR - Argentina 33
CA - Canada 32
MX - Messico 28
CH - Svizzera 27
GB - Regno Unito 17
IN - India 15
RU - Federazione Russa 14
IQ - Iraq 13
JM - Giamaica 10
NL - Olanda 10
IE - Irlanda 9
ID - Indonesia 8
CO - Colombia 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
CL - Cile 6
JO - Giordania 6
MA - Marocco 6
PL - Polonia 6
TH - Thailandia 6
UY - Uruguay 6
VE - Venezuela 6
EC - Ecuador 5
PH - Filippine 5
ZA - Sudafrica 5
KE - Kenya 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CR - Costa Rica 3
DZ - Algeria 3
GR - Grecia 3
KZ - Kazakistan 3
PK - Pakistan 3
SE - Svezia 3
TN - Tunisia 3
TR - Turchia 3
AT - Austria 2
AU - Australia 2
EG - Egitto 2
ES - Italia 2
ET - Etiopia 2
IR - Iran 2
KW - Kuwait 2
NG - Nigeria 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
RS - Serbia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UA - Ucraina 2
AG - Antigua e Barbuda 1
BG - Bulgaria 1
BM - Bermuda 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
GP - Guadalupe 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
KR - Corea 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LT - Lituania 1
ML - Mali 1
MM - Myanmar 1
MT - Malta 1
MY - Malesia 1
NO - Norvegia 1
PR - Porto Rico 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TG - Togo 1
Totale 25.675
Salva come PNG Salva come JPEG
Città #
Genova 13.268
Genoa 5.220
Rapallo 1.944
Vado Ligure 1.297
Singapore 397
San Jose 380
Lauterbourg 171
Ho Chi Minh City 113
Beijing 82
Ashburn 79
Hanoi 75
Hong Kong 74
New York 69
Helsinki 52
Bordighera 38
Council Bluffs 38
Santa Clara 37
Frankfurt am Main 36
Tokyo 24
Zurich 24
Haiphong 19
Milan 19
Los Angeles 17
Mexico City 17
Da Nang 14
São Paulo 14
Orem 12
San Francisco 12
Atlanta 10
Chicago 10
Buffalo 9
Dallas 9
Montreal 9
Rome 9
Tianjin 9
Phoenix 8
Biên Hòa 7
Dublin 7
Amsterdam 6
Baghdad 6
Buenos Aires 6
Guangzhou 6
Houston 6
Hải Dương 6
Palermo 6
Valenza 6
London 5
Tashkent 5
Warsaw 5
Amman 4
Boardman 4
Cagliari 4
City of London 4
Hưng Yên 4
Marseille 4
Montevideo 4
Mumbai 4
Ninh Bình 4
Phủ Lý 4
Thái Nguyên 4
Toronto 4
Turin 4
Baku 3
Bologna 3
Brasília 3
Brooklyn 3
Bắc Giang 3
Can Tho 3
Denver 3
Hangzhou 3
Kingston 3
Lahore 3
Las Vegas 3
Long Xuyen 3
Manchester 3
Montego Bay 3
Nairobi 3
Naples 3
New Delhi 3
Osaka 3
Quận Ba 3
Rio de Janeiro 3
Rovereto 3
Santiago 3
Thái Bình 3
Tunis 3
Zhengzhou 3
Addis Ababa 2
Athens 2
Bangkok 2
Belgrade 2
Benito Juarez 2
Brantford 2
Cao Lanh 2
Cape Coral 2
Cardiff 2
Casablanca 2
Chennai 2
Colombo 2
Columbus 2
Totale 23.845
Salva come PNG Salva come JPEG
Nome #
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 304
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 274
Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry 252
CDKN2A is the main susceptibility gene in Italian pancreatic cancer families. 241
A combination of immunohistochemistry and molecular approaches improves highly sensitive detection of BRAF mutations in papillary thyroid cancer 222
Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. 217
Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy. 211
Association of MC1R Variants and Host Phenotypes With Melanoma Risk in CDKN2A Mutation Carriers: A GenoMEL Study 210
Pathway-based analysis of a melanoma genome-wide association study: analysis of genes related to tumour-immunosuppression. 210
An upstream positive regulatory element in human GM-CSF promoter is recognized by NF-kB/Rel family members 205
Granulocyte-macrophage colony-stimulating factor activity in cerebrospinal fluid 201
Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome. 196
Incidence of other neoplasia in Italian melanoma-prone families with p16 (GLy93Trp) mutation 195
CDKN2A and MC1R analysis in amelanotic and pigmented melanoma. 193
H and L ferritin gene expression in U937 cells induced to macrophagedifferentiation 192
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL 191
Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanoma 189
Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patients. 186
Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148 186
Association of Genetic Variants in CDK6 and XRCC1 with the Risk of Dysplastic Nevi in Melanoma-Prone Families. 185
c-Rel and p65 subunits bind to an upstream NF-kB site in human granulocyte macrophage-colony stimulating factor promoter involved in phorbol ester response in 5637 cells 183
A flexible multiplex bead-based assay for detecting germline CDKN2A and CDK4 variants in melanoma-prone kindreds 183
Discovery of a novel glucose metabolism in cancer: The role of endoplasmic reticulum beyond glycolysis and pentose phosphate shunt 183
A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL) 183
Cell-type–specific eQTL of primary melanocytes facilitates identification of melanoma susceptibility genes 183
Brooke-Spiegler syndrome tumor spectrum beyond the skin: a patient carrying germline R936X CYLD mutation and a somatic CYLDmutation in Brenner tumor 182
CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation 180
Increased Risk of Colorectal Adenomas in Italian Subjects Carrying the p53 PIN3 A2-Pro72 Haplotype. 178
Cytokine expression in human primary and metastatic melanoma cells: analysis in fresh bioptic specimens 177
A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone-families 175
ANALISI GENOME-WIDE PER LA SUSCETTIBILITÀ AL MELANOMA: NUOVI LOCICHE CONFERMANO IL RUOLO DEI GENI DELLA PIGMENTAZIONE 173
Gly101Trp germline mutation in the CDKN2A gene in familial and non familial Ligurian melanoma patients 172
A variant in FTO shows association with melanoma risk not due to BMI. 172
Features associated with germline CDKN2A mutations: A GenoMEL study of melanoma-prone families from three continents 171
Familial Melanoma and Pancreatic Cancer 170
A case of chronic myelogenous leukemia with unusual chromosomal abnormality. 170
Molecular characterization of an Italian series of sporadic GISTs. 167
Clinical genetic testing for familial melanoma in Italy: a cooperative study. 163
Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma 160
Genome-wide association study identifies three new melanoma susceptibility loci 160
An upstream negative regulatory element in human granulocyte-macrophage colony-stimulating factor promoter is recognised by AP1 family members 159
Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in Italian melanoma families displaying pancreatic cancer and neuroblastoma. 157
Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history. 156
Novel PTCH1 Mutations in Patients with Keratocystic Odontogenic Tumors Screened for Nevoid Basal Cell Carcinoma (NBCC) Syndrome 155
Nevoid Basal Cell Carcinoma Syndrome in infants: improving diagnosis. 153
Absence of high risk gene mutations in hereditary melanoma points to the interplay between somatic and low risk germline variants 153
Fine mapping of genetic susceptibility loci for melanoma reveals a mixture of single variant and multiple variant regions. 153
Genetic testing for melanoma 152
Intercellular adhesion molecule-1 (ICAM-1) and granulocyte-macrophage colony stimulating factor (GM-CSF) co-expression in cutaneous malignant melanoma lesions. 150
Characterization of a triplex DNA-binding protein encoded by an alternative reading frame of loricrin 149
Analysis of p16 protein expression in familial melanoma patients: correlation with germline status. 149
Electrophoretic pattern of NADPH - dependent oxidoreductive activities in the K562 and HL60 leukemic cell lines 149
Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3 149
"Gestione Melanoma" un "database" relazionale per lo studio e l’approfondimento della relazione genotipo/fenotipo e genotipo/ambiente nel melanoma familiare e sporadico 148
Varianti polimorfiche del gene MC1R (Melanocortin receptor 1) nella popolazione ligure ed associazione con il rischio di melanoma 148
Effect of primaquine on erythrocytes with NADH-methaemoglobin reductase deficiency and low glutathione reductase activity. 146
Coexisting NRAS and BRAF Mutations in Primary Familial Melanomas with Specific CDKN2A Germline Alterations. 146
High prevalence of the G101W germline mutation in the CDKN2A (P16INK4A) gene in 62 Italian malignant melanoma families 146
CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma 146
Identification of a SUFU germline mutation in a family with Gorlin syndrome 145
Somatic BRAF and NRAS Mutations in Familial Melanomas with Known Germline CDKN2A Status: A GenoMEL Study. 145
3’UTR polymorphisms in the CDKN2A gene and age at onset of familial and sporadic melanoma 144
Role of the EGF +61A>G polymorphism in melanoma pathogenesis: an experience on a large series of Italian cases and controls. 144
MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patients. 144
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 143
High prevalence of the Gly101Trp germline mutation in the CDKN2A gene in 62 small Italian families 143
What is new in melanoma research: genetics and epidemiology of melanoma in 2003? Review of a workshop held in Milan in May 2003 142
Linkage Analysis in melanoma prone families 142
Urinary granulopoietic activity in chronic myelogenous leukemia: follow-up and correlation with various phases of the disease. 142
Absence of melanocortin 1 receptor variants in Ligurian G101W families 142
Lactoferrin as a possible transcriptional regulator 142
Hereditary trichilemmal cysts: A proposal for the assessment of diagnostic clinical criteria 142
On the Xq13 breakpoint: clinical and cytogenetic observations in a patient with acute myelogenous leukemia. 141
The 5'-untranslated region of p16INK4a melanoma tumor suppressor acts as a cellular IRES, controlling mRNA translation under hypoxia through YBX1 binding 141
3’UTR polymorphisms in the CDKN2A gene and age at onset of familial and sporadic melanoma from Liguria 141
CDKN2A germline mutation analysis in patients with pancreatic adenocarcinoma 140
BRAF gene is somatically mutated but does not make a major contribution to malignant melanoma susceptibility: the Italian Melanoma Intergroup Study 140
A nuclear factor that Down-Modulates the Granulocyte-Macrophage Colony-Stimulating Factor Expression. 140
Patched homolog 1 gene mutation (p.G1093R) induces nevoid basal cell carcinoma syndrome and non-syndromic keratocystic odontogenic tumors: A case report. 140
Characterization of Ligurian Melanoma families and risk of occurence of other neoplasia 140
Italian Melanoma-prone Families:Germline mutational analysis and Clinical-Epidemiological Characterization 139
Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients 138
The role of AIRE polymorphisms in melanoma. 138
Five novel germline function-impairing mutations of CYLD in Italian patients with multiple cylindromas 138
Mutation screening of the CDKN2A promoter melanoma families 137
Expression and genomic configuration of GM-CSF, IL-3, M-CSFreceptor (C-FMS), early growth response gene-1 (EGR-1) and M-CSF genes in primary myelodysplastic syndromes 137
Unusual Ph translocations in CML: four new cases 137
Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma 137
Genomic rearrangements of the CDKN2A locus are infrequent in Italian malignant melanoma families without evidence of CDKN2A/CDK4 point mutations 137
CDKN2A Unclassified Variants in Familial Malignant Melanoma: Combining Functional and Computational Approaches for Their Assessment 134
Effect of endothelial cell conditioned medium on the growth of human bone marrow fibroblasts 133
MDM2 SNP309 genotype influences survival of metastatic but not of localized neuroblastoma 132
Inverse correlation between p16INK4A expression and NF-kappaB activation in melanoma progression 132
Masked Philadelphia chromosome caused by translocation (9;11;22) 132
Analisi del gene della p16ink4 in pazienti con melanoma familiare e sporadico 131
Ink4/ARF germline mutations and additional neoplasia in pancretic cancer patients and their families 131
Novel MC1R variants in Ligurian melanoma patients and controls 131
Karyotype evolution in a case of chronic myelogenous leukemia with an unusual Philadelphia chromosome translocation, t(4;22), and an additional translocation, t(3;5). 131
Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways 131
CDKN2A germline mutation analysis in patients with pancreatic adenocarcinoma from Liguria 130
Totale 16.278
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.076
article - articoli 59.749
book - libri 0
conference - conferenze 17.465
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.862
Totale 158.152
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021107 0 0 0 0 0 0 0 0 0 0 0 107
2021/20222.199 46 191 149 296 103 129 158 526 71 204 76 250
2022/20232.387 273 152 16 215 478 420 14 139 372 15 249 44
2023/20241.163 60 147 16 120 87 221 69 59 95 27 60 202
2024/20253.575 130 262 130 248 363 386 436 632 185 123 276 404
2025/20265.290 686 130 245 503 697 602 927 215 373 504 360 48
Totale 25.856